Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

aTYR PHARMA INC (LIFE)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Dec-05-22Dec-31-21Dec-05-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17
   10-K8-K10-K8-K10-K10-K10-K10-K
Total revenues   [+]10.410.40.023.310.50.40.00.0
            Revenue growth   -55.4%-100.0% 2377.5%   
Cost of goods sold  0.056.80.034.00.00.00.00.0
Gross profit  10.4-46.40.0-10.810.50.40.00.0
            Gross margin  100.0%-446.8% -46.2%100.0%100.0%  
Selling, general and administrative   [+]56.814.034.010.826.49.412.417.1
Research and development       14.020.430.1
Other operating expenses  -2.1-14.0-0.512.50.6   
EBITDA   [+]-44.0 -33.1 -16.0-22.3-32.1-46.4
            EBITDA margin  -424.1%-446.8% -146.2%-152.8%-5294.5%  
Depreciation and amortization  0.2 0.5 0.60.60.70.7
EBIT   [+]-44.3-46.4-33.5-34.0-16.5-23.0-32.8-47.1
            EBIT margin  -426.3%-446.8% -146.2%-158.3%-5445.0%  
Other income (expense), net  -1.11.1-0.20.20.3-0.8-1.7-1.1
Pre-tax income  -45.3-45.3-33.8-33.8-16.2-23.8-34.5-48.2
Income taxes  0.00.00.00.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Minority interest       -0.2  
Net income  -45.3-45.3-33.8-33.8-16.2-23.6-34.5-48.2
            Net margin  -436.5%-436.5% -145.2%-155.2%-5593.1%  
   
Basic EPS   [+]($1.60)($1.60)($1.77)($1.77)($1.77)($7.03)($16.11)($26.13)
Diluted EPS   [+]($1.60)($1.60)($1.77)($1.77)($1.77)($7.03)($16.11)($26.13)
   
Shares outstanding (basic)   [+]28.428.419.119.19.23.42.11.8
Shares outstanding (diluted)   [+]28.428.419.119.19.23.42.11.8
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy